United States
US 12,702,707 B2
Modified mRNA vaccines encoding herpes simplex virus glycoproteins and uses thereof
US 12,702,707 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
- Inventors
- Harvey FRIEDMAN; Drew WEISSMAN; Sita AWASTHI; Gary Cohen
- Publication date
- 2026-08-11
- Filing date
- 2023-09-19
- Document type
- B2 Granted patent
- Also written as
- US 12,702,707 B2 · US12702707 · 12702707
Abstract
The present invention provides compositions for the prevention and treatment of genital herpes, comprising nucleoside modified mRNAs that encode herpes simplex virus (HSV) glycoproteins, including those involved in virus entry and immune evasion, and methods of use thereof.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free